AHF Asks State Health Departments & AIDS Directors, Private Insurers to Place Gilead’s New ‘Quad’ Pill on ‘Prior Authorization’ Status
15:22 EDT 17 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
In what may be an unprecedented move on drug pricing and access,
advocates from AIDS
Healthcare Foundation, are calling on state AIDS and
Medicaid directors as well as a number of private medical insurers
nationwide askin...
Other Sources for this Article
AIDS Healthcare Foundation
Ged Kenslea, Communications
Director
Office: 323-308-1833
Cell: 323-791-5526
gedk@aidshealth.org
More From BioPortfolio on "AHF Asks State Health Departments & AIDS Directors, Private Insurers to Place Gilead’s New ‘Quad’ Pill on ‘Prior Authorization’ Status"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
